According to A Latest intelligence report published by Market IntelliX, the global market for Consumer Healthcare Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Consumer Healthcare Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Consumer Healthcare Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Solid Preparations segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Consumer Healthcare Drug include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Takeda, Bayer and Teva, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.

This report aims to provide a comprehensive study of the global market for Consumer Healthcare Drug. Report Highlights:

(1) Global Consumer Healthcare Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Consumer Healthcare Drug market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Consumer Healthcare Drug market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Consumer Healthcare Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Consumer Healthcare Drug segment by type and by application and regional segment by type and by application.

(6) Consumer Healthcare Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Solid Preparations

Oral Liquid

Patch

Other

Market segment by application, can be divided into

Hospital

Retail Pharmacy

Other

Market segment by players, this report covers

Johnson & Johnson

AbbVie

Merck & Co.

GlaxoSmithKline

Pfizer

Sanofi

Takeda

Bayer

Teva

Sinopharm Group

CR Pharmaceutical

Shanghai Pharmaceuticals

Hualan Bio

North China Pharmaceutical

Hengrui Medicine

Fosun Pharma

East China Medicine

Livzon Group

1 Market Overview

1.1 Product Overview and Scope of Consumer Healthcare Drug

1.2 Global Consumer Healthcare Drug Market Size and Forecast

1.3 China Consumer Healthcare Drug Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Consumer Healthcare Drug Share in Global Market, 2018-2029

1.4.2 Consumer Healthcare Drug Market Size: China VS Global, 2018-2029

1.5 Consumer Healthcare Drug Market Dynamics

1.5.1 Consumer Healthcare Drug Market Drivers

1.5.2 Consumer Healthcare Drug Market Restraints

1.5.3 Consumer Healthcare Drug Industry Trends

1.5.4 Consumer Healthcare Drug Industry Policy

2 Global Competitive Situation by Company

2.1 Global Consumer Healthcare Drug Revenue by Company (2018-2023)

2.2 Global Consumer Healthcare Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Consumer Healthcare Drug Concentration Ratio

2.4 Global Consumer Healthcare Drug Mergers & Acquisitions, Expansion Plans

2.5 Global Consumer Healthcare Drug Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Consumer Healthcare Drug Revenue by Company (2018-2023)

3.2 China Consumer Healthcare Drug Consumer Healthcare Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Consumer Healthcare Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Consumer Healthcare Drug Industry Chain

4.2 Consumer Healthcare Drug Upstream Analysis

4.3 Consumer Healthcare Drug Midstream Analysis

4.4 Consumer Healthcare Drug Downstream Analysis

5 Sights by Type

5.1 Consumer Healthcare Drug Classification

5.1.1 Solid Preparations

5.1.2 Oral Liquid

5.1.3 Patch

5.1.4 Other

5.2 By Type, Global Consumer Healthcare Drug Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Consumer Healthcare Drug Revenue, 2018-2029

6 Sights by Application

6.1 Consumer Healthcare Drug Segment by Application

6.1.1 Hospital

6.1.2 Retail Pharmacy

6.1.3 Other

6.2 By Application, Global Consumer Healthcare Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Consumer Healthcare Drug Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Consumer Healthcare Drug Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Consumer Healthcare Drug Market Size, 2018-2029

7.3 North America

7.3.1 North America Consumer Healthcare Drug Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Consumer Healthcare Drug Market Size Market Share

7.4 Europe

7.4.1 Europe Consumer Healthcare Drug Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Consumer Healthcare Drug Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Consumer Healthcare Drug Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Consumer Healthcare Drug Market Size Market Share

7.6 South America

7.6.1 South America Consumer Healthcare Drug Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Consumer Healthcare Drug Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Consumer Healthcare Drug Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Consumer Healthcare Drug Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Consumer Healthcare Drug Market Size, 2018-2029

8.3.2 By Company, U.S. Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Consumer Healthcare Drug Market Size, 2018-2029

8.4.2 By Company, Europe Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Consumer Healthcare Drug Market Size, 2018-2029

8.5.2 By Company, China Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.5.3 By Type, China Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Consumer Healthcare Drug Market Size, 2018-2029

8.6.2 By Company, Japan Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Consumer Healthcare Drug Market Size, 2018-2029

8.7.2 By Company, South Korea Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Consumer Healthcare Drug Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Consumer Healthcare Drug Market Size, 2018-2029

8.9.2 By Company, India Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.9.3 By Type, India Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Consumer Healthcare Drug Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Consumer Healthcare Drug Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Johnson & Johnson

9.1.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.1.2 Johnson & Johnson Company Profile and Main Business

9.1.3 Johnson & Johnson Consumer Healthcare Drug Models, Specifications and Application

9.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.1.5 Johnson & Johnson Recent Developments

9.2 AbbVie

9.2.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.2.2 AbbVie Company Profile and Main Business

9.2.3 AbbVie Consumer Healthcare Drug Models, Specifications and Application

9.2.4 AbbVie Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.2.5 AbbVie Recent Developments

9.3 Merck & Co.

9.3.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position

9.3.2 Merck & Co. Company Profile and Main Business

9.3.3 Merck & Co. Consumer Healthcare Drug Models, Specifications and Application

9.3.4 Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.3.5 Merck & Co. Recent Developments

9.4 GlaxoSmithKline

9.4.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

9.4.2 GlaxoSmithKline Company Profile and Main Business

9.4.3 GlaxoSmithKline Consumer Healthcare Drug Models, Specifications and Application

9.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.4.5 GlaxoSmithKline Recent Developments

9.5 Pfizer

9.5.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.5.2 Pfizer Company Profile and Main Business

9.5.3 Pfizer Consumer Healthcare Drug Models, Specifications and Application

9.5.4 Pfizer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.5.5 Pfizer Recent Developments

9.6 Sanofi

9.6.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.6.2 Sanofi Company Profile and Main Business

9.6.3 Sanofi Consumer Healthcare Drug Models, Specifications and Application

9.6.4 Sanofi Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.6.5 Sanofi Recent Developments

9.7 Takeda

9.7.1 Takeda Company Information, Head Office, Market Area and Industry Position

9.7.2 Takeda Company Profile and Main Business

9.7.3 Takeda Consumer Healthcare Drug Models, Specifications and Application

9.7.4 Takeda Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.7.5 Takeda Recent Developments

9.8 Bayer

9.8.1 Bayer Company Information, Head Office, Market Area and Industry Position

9.8.2 Bayer Company Profile and Main Business

9.8.3 Bayer Consumer Healthcare Drug Models, Specifications and Application

9.8.4 Bayer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.8.5 Bayer Recent Developments

9.9 Teva

9.9.1 Teva Company Information, Head Office, Market Area and Industry Position

9.9.2 Teva Company Profile and Main Business

9.9.3 Teva Consumer Healthcare Drug Models, Specifications and Application

9.9.4 Teva Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.9.5 Teva Recent Developments

9.10 Sinopharm Group

9.10.1 Sinopharm Group Company Information, Head Office, Market Area and Industry Position

9.10.2 Sinopharm Group Company Profile and Main Business

9.10.3 Sinopharm Group Consumer Healthcare Drug Models, Specifications and Application

9.10.4 Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.10.5 Sinopharm Group Recent Developments

9.11 CR Pharmaceutical

9.11.1 CR Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.11.2 CR Pharmaceutical Company Profile and Main Business

9.11.3 CR Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application

9.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.11.5 CR Pharmaceutical Recent Developments

9.12 Shanghai Pharmaceuticals

9.12.1 Shanghai Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.12.2 Shanghai Pharmaceuticals Company Profile and Main Business

9.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Models, Specifications and Application

9.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.12.5 Shanghai Pharmaceuticals Recent Developments

9.13 Hualan Bio

9.13.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position

9.13.2 Hualan Bio Company Profile and Main Business

9.13.3 Hualan Bio Consumer Healthcare Drug Models, Specifications and Application

9.13.4 Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.13.5 Hualan Bio Recent Developments

9.14 North China Pharmaceutical

9.14.1 North China Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.14.2 North China Pharmaceutical Company Profile and Main Business

9.14.3 North China Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application

9.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.14.5 North China Pharmaceutical Recent Developments

9.15 Hengrui Medicine

9.15.1 Hengrui Medicine Company Information, Head Office, Market Area and Industry Position

9.15.2 Hengrui Medicine Company Profile and Main Business

9.15.3 Hengrui Medicine Consumer Healthcare Drug Models, Specifications and Application

9.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.15.5 Hengrui Medicine Recent Developments

9.16 Fosun Pharma

9.16.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position

9.16.2 Fosun Pharma Company Profile and Main Business

9.16.3 Fosun Pharma Consumer Healthcare Drug Models, Specifications and Application

9.16.4 Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.16.5 Fosun Pharma Recent Developments

9.17 East China Medicine

9.17.1 East China Medicine Company Information, Head Office, Market Area and Industry Position

9.17.2 East China Medicine Company Profile and Main Business

9.17.3 East China Medicine Consumer Healthcare Drug Models, Specifications and Application

9.17.4 East China Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.17.5 East China Medicine Recent Developments

9.18 Livzon Group

9.18.1 Livzon Group Company Information, Head Office, Market Area and Industry Position

9.18.2 Livzon Group Company Profile and Main Business

9.18.3 Livzon Group Consumer Healthcare Drug Models, Specifications and Application

9.18.4 Livzon Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

9.18.5 Livzon Group Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Consumer Healthcare Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Consumer Healthcare Drug Market Restraints

Table 3. Consumer Healthcare Drug Market Trends

Table 4. Consumer Healthcare Drug Industry Policy

Table 5. Global Consumer Healthcare Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Consumer Healthcare Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Consumer Healthcare Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Consumer Healthcare Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Consumer Healthcare Drug Manufacturers Product Type

Table 10. China Consumer Healthcare Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Consumer Healthcare Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Consumer Healthcare Drug Upstream (Raw Materials)

Table 13. Global Consumer Healthcare Drug Typical Customers

Table 14. Consumer Healthcare Drug Typical Distributors

Table 15. By Type, Global Consumer Healthcare Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Consumer Healthcare Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Consumer Healthcare Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Consumer Healthcare Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Consumer Healthcare Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Consumer Healthcare Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Consumer Healthcare Drug Revenue Market Share, 2018-2029

Table 22. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 23. Johnson & Johnson Company Profile and Main Business

Table 24. Johnson & Johnson Consumer Healthcare Drug Models, Specifications and Application

Table 25. Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 26. Johnson & Johnson Recent Developments

Table 27. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 28. AbbVie Company Profile and Main Business

Table 29. AbbVie Consumer Healthcare Drug Models, Specifications and Application

Table 30. AbbVie Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 31. AbbVie Recent Developments

Table 32. Merck & Co. Company Information, Head Office, Market Area and Industry Position

Table 33. Merck & Co. Company Profile and Main Business

Table 34. Merck & Co. Consumer Healthcare Drug Models, Specifications and Application

Table 35. Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 36. Merck & Co. Recent Developments

Table 37. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 38. GlaxoSmithKline Company Profile and Main Business

Table 39. GlaxoSmithKline Consumer Healthcare Drug Models, Specifications and Application

Table 40. GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 41. GlaxoSmithKline Recent Developments

Table 42. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 43. Pfizer Company Profile and Main Business

Table 44. Pfizer Consumer Healthcare Drug Models, Specifications and Application

Table 45. Pfizer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 46. Pfizer Recent Developments

Table 47. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 48. Sanofi Company Profile and Main Business

Table 49. Sanofi Consumer Healthcare Drug Models, Specifications and Application

Table 50. Sanofi Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 51. Sanofi Recent Developments

Table 52. Takeda Company Information, Head Office, Market Area and Industry Position

Table 53. Takeda Company Profile and Main Business

Table 54. Takeda Consumer Healthcare Drug Models, Specifications and Application

Table 55. Takeda Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 56. Takeda Recent Developments

Table 57. Bayer Company Information, Head Office, Market Area and Industry Position

Table 58. Bayer Company Profile and Main Business

Table 59. Bayer Consumer Healthcare Drug Models, Specifications and Application

Table 60. Bayer Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 61. Bayer Recent Developments

Table 62. Teva Company Information, Head Office, Market Area and Industry Position

Table 63. Teva Company Profile and Main Business

Table 64. Teva Consumer Healthcare Drug Models, Specifications and Application

Table 65. Teva Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 66. Teva Recent Developments

Table 67. Sinopharm Group Company Information, Head Office, Market Area and Industry Position

Table 68. Sinopharm Group Company Profile and Main Business

Table 69. Sinopharm Group Consumer Healthcare Drug Models, Specifications and Application

Table 70. Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 71. Sinopharm Group Recent Developments

Table 72. CR Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 73. CR Pharmaceutical Company Profile and Main Business

Table 74. CR Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application

Table 75. CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 76. CR Pharmaceutical Recent Developments

Table 77. Shanghai Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 78. Shanghai Pharmaceuticals Company Profile and Main Business

Table 79. Shanghai Pharmaceuticals Consumer Healthcare Drug Models, Specifications and Application

Table 80. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 81. Shanghai Pharmaceuticals Recent Developments

Table 82. Hualan Bio Company Information, Head Office, Market Area and Industry Position

Table 83. Hualan Bio Company Profile and Main Business

Table 84. Hualan Bio Consumer Healthcare Drug Models, Specifications and Application

Table 85. Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 86. Hualan Bio Recent Developments

Table 87. North China Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 88. North China Pharmaceutical Company Profile and Main Business

Table 89. North China Pharmaceutical Consumer Healthcare Drug Models, Specifications and Application

Table 90. North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 91. North China Pharmaceutical Recent Developments

Table 92. Hengrui Medicine Company Information, Head Office, Market Area and Industry Position

Table 93. Hengrui Medicine Company Profile and Main Business

Table 94. Hengrui Medicine Consumer Healthcare Drug Models, Specifications and Application

Table 95. Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 96. Hengrui Medicine Recent Developments

Table 97. Fosun Pharma Company Information, Head Office, Market Area and Industry Position

Table 98. Fosun Pharma Company Profile and Main Business

Table 99. Fosun Pharma Consumer Healthcare Drug Models, Specifications and Application

Table 100. Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 101. Fosun Pharma Recent Developments

Table 102. East China Medicine Company Information, Head Office, Market Area and Industry Position

Table 103. East China Medicine Company Profile and Main Business

Table 104. East China Medicine Consumer Healthcare Drug Models, Specifications and Application

Table 105. East China Medicine Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 106. East China Medicine Recent Developments

Table 107. Livzon Group Company Information, Head Office, Market Area and Industry Position

Table 108. Livzon Group Company Profile and Main Business

Table 109. Livzon Group Consumer Healthcare Drug Models, Specifications and Application

Table 110. Livzon Group Consumer Healthcare Drug Revenue and Gross Margin, 2018-2023

Table 111. Livzon Group Recent Developments

List of Figure

Figure 1. Consumer Healthcare Drug Picture

Figure 2. Global Consumer Healthcare Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Consumer Healthcare Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Consumer Healthcare Drug Market Share of Global

Figure 5. Global Consumer Healthcare Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Consumer Healthcare Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Consumer Healthcare Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Consumer Healthcare Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Consumer Healthcare Drug Industry Chain

Figure 10. Solid Preparations

Figure 11. Oral Liquid

Figure 12. Patch

Figure 13. Other

Figure 14. By Type, Global Consumer Healthcare Drug Revenue, 2018-2029, US$ Million

Figure 15. By Type, Global Consumer Healthcare Drug Revenue Market Share, 2018-2029

Figure 16. Hospital

Figure 17. Retail Pharmacy

Figure 18. Other

Figure 19. By Application, Global Consumer Healthcare Drug Revenue, 2018-2029, US$ Million

Figure 20. By Application, Global Consumer Healthcare Drug Revenue Market Share, 2018-2029

Figure 21. By Region, Global Consumer Healthcare Drug Revenue Market Share, 2018-2029

Figure 22. North America Consumer Healthcare Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, North America Consumer Healthcare Drug Revenue Market Share, 2018-2023

Figure 24. Europe Consumer Healthcare Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, Europe Consumer Healthcare Drug Revenue Market Share, 2018-2023

Figure 26. Asia Pacific Consumer Healthcare Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country/Region, Asia Pacific Consumer Healthcare Drug Revenue Market Share, 2018-2023

Figure 28. South America Consumer Healthcare Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country, South America Consumer Healthcare Drug Revenue Market Share, 2018-2023

Figure 30. Middle East & Africa Consumer Healthcare Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. U.S. Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 32. By Company, U.S. Consumer Healthcare Drug Market Share, 2018-2023

Figure 33. By Type, U.S. Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 34. By Application, U.S. Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 35. Europe Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 36. By Company, Europe Consumer Healthcare Drug Market Share, 2018-2023

Figure 37. By Type, Europe Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 38. By Application, Europe Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 39. China Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 40. By Company, China Consumer Healthcare Drug Market Share, 2018-2023

Figure 41. By Type, China Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 42. By Application, China Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 43. Japan Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 44. By Company, Japan Consumer Healthcare Drug Market Share, 2018-2023

Figure 45. By Type, Japan Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 46. By Application, Japan Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 47. South Korea Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 48. By Company, South Korea Consumer Healthcare Drug Market Share, 2018-2023

Figure 49. By Type, South Korea Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 50. By Application, South Korea Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 51. Southeast Asia Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 52. By Company, Southeast Asia Consumer Healthcare Drug Market Share, 2018-2023

Figure 53. By Type, Southeast Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 54. By Application, Southeast Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 55. India Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 56. By Company, India Consumer Healthcare Drug Market Share, 2018-2023

Figure 57. By Type, India Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 58. By Application, India Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 59. Middle East & Asia Consumer Healthcare Drug Revenue, 2018-2029, (US$ Million)

Figure 60. By Company, Middle East & Asia Consumer Healthcare Drug Market Share, 2018-2023

Figure 61. By Type, Middle East & Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 62. By Application, Middle East & Asia Consumer Healthcare Drug Revenue Market Share, 2022 VS 2029

Figure 63. Research Methodology

Figure 64. Breakdown of Primary Interviews

Figure 65. Bottom-up Approaches

Figure 66. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)